A preparation method of ibuprofen sustained-release capsules

By using polyvinylpyrrolidone as a drug binder and pore-making agent in ibuprofen sustained-release capsules, the problems of instability in dissolution value and coating density are solved, and better sustained-release effect is achieved. and production efficiency.

CN118286183BActive Publication Date: 2024-11-12HAINAN MIAOYINCHUN PHARM CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410375417.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-29
Publication Date
2024-11-12
Estimated Expiration
2044-03-29

AI Technical Summary

Technical Problem

The dissolution value of existing ibuprofen sustained-release capsules is unstable and low, and the density of the drug layer coating affects the sustained-release effect and has low production efficiency.

Method used

Polyvinylpyrrolidone is used as a drug adhesive and pore-making agent, and double-layer coating is carried out through a centrifugal coating machine to improve the adhesion and permeability of the drug on the isolation layer, form a uniform and fine pore structure, and control drug release. rate.

Benefits of technology

It improves the solubility and bioavailability of ibuprofen sustained-release capsules, enhances the sustained-release performance, stabilizes the drug release curve, reduces the number of medications and gastrointestinal stimulation, and improves production efficiency.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention discloses a method for preparing ibuprofen sustained-release capsules. The preparation method comprises the following steps: adding an isolation layer auxiliary material to ethanol, stirring until dissolved, starting a centrifugal coating machine, adding a pellet core, stopping the liquid spraying after coating, drying, and obtaining an isolation layer micro-pill; sequentially adding polyvinyl pyrrolidone and ibuprofen to ethanol, stirring until dissolved, starting a centrifugal coating machine, adding an isolation layer micro-pill, stopping the liquid spraying after coating, drying, and obtaining ibuprofen micro-pills; adding the ibuprofen micro-pills to a mixer for mixing; converting the filling amount according to the content of ibuprofen, and filling it into a capsule shell to obtain the ibuprofen sustained-release capsule. Compared with the prior art, the ibuprofen sustained-release capsule prepared by the present invention achieves sustained-release performance by making ibuprofen itself insoluble and improving the coating density, while improving production efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of antipyretic analgesics, and in particular to a method for preparing ibuprofen sustained-release capsules. Background Art

[0002] Ibuprofen, also known as ibuprofen, is a phenylpropionic acid nonsteroidal anti-inflammatory drug. It has significant anti-inflammatory, analgesic and antipyretic effects, with relatively few adverse reactions. It is widely used worldwide and has become one of the world's best-selling over-the-counter drugs. Ibuprofen has been steadily increasing in sales in my country's pharmaceutical market. Together with paracetamol, aspirin and diclofenac, it has become one of the four pillar products in the antipyretic and analgesic market. Ibuprofen has both anti-rheumatic and antipyretic and analgesic effects, and has low toxicity. It is superior to aspirin and paracetamol in terms of efficacy and side effects, so the market is expanding rapidly.

[0003] 1991, Ibuprofen sustained-release capsules Launched in China, its unique 12-hour sustained-release technology has successfully filled the gap in my country's sustained-release capsule manufacturing process. Compared with ordinary ibuprofen, ibuprofen sustained-release capsules have significant clinical effects, including the following: maintaining the effective blood concentration of ibuprofen overnight, thereby preventing the occurrence of morning stiffness and pain; controlling the blood concentration of ibuprofen at an appropriate level to avoid side effects caused by excessively high peak values ​​and symptoms caused by excessively low trough values ​​due to multiple dosing; keeping the local concentration in the gastrointestinal tract low to minimize irritation to the gastrointestinal tract; reducing the number of medications to twice a day, once in the morning and once in the evening, enhancing patient compliance. In recent years, many companies have researched and released a variety of related technologies to achieve the effect of sustained release and be consistent with the reference preparation in vivo and in vitro.

[0004] Chinese patent CN 115120575A discloses a method for preparing ibuprofen sustained-release capsules, wherein the preparation method comprises the following specific steps: dissolving the raw material main drug, sustained-release material and pore-forming agent of ibuprofen sustained-release capsules in a solvent in sequence to obtain a drug layer solution; placing a blank pill core in a fluidized bed for preheating; coating the blank pill core with the drug layer solution by bottom spraying to obtain ibuprofen sustained-release bottom-spray coated micro-pellets; drying the ibuprofen sustained-release bottom-spray coated micro-pellets, sieving twice, and then centrifugally polishing them with a centrifugal granulator to obtain ibuprofen sustained-release micro-pellets; loading the ibuprofen sustained-release micro-pellets into a capsule shell to obtain ibuprofen sustained-release capsules. The prescription composition of the present invention is simple, containing only the main drug, sustained-release material and pore-forming agent, and the medication is safe and will not increase the burden on patients. The preparation process is simple and easy to operate, and is a fluidized bed bottom spraying layer-level drug application process and a centrifugal granulator polishing process, and the drug properties are white waxy and dense micro-pellets.

[0005] Chinese patent CN 111481527A discloses a method for preparing ibuprofen sustained-release capsules, comprising the following steps: A. using anhydrous ethanol and polyvinyl pyrrolidone to prepare an anhydrous ethanol solution of polyvinyl pyrrolidone with a mass concentration of 6.8-7.3%, as a binder, for standby use; B. weighing the sucrose pellet core, placing it in a multifunctional pellet coating machine, and preheating it to 26-28°C; then adjusting the operating parameters of the multifunctional pellet coating machine, adding ibuprofen powder and spraying the binder to prepare ibuprofen sustained-release capsule micro-pills. The method for improving the yield of ibuprofen sustained-release capsules of the invention greatly improves the yield of ibuprofen sustained-release capsules by appropriately increasing the concentration of the binder, reduces the generation of tailings, and has good powdering effect and excellent appearance of micro-pills.

[0006] The solutions reported in the above patent documents are to only coat ibuprofen on the pellet core to obtain ibuprofen sustained-release capsules, which cannot solve the problem that the dissolution value of ibuprofen sustained-release capsules is unstable and low, and the density of the drug layer coating will directly affect the effect. Summary of the invention

[0007] In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to achieve sustained-release performance by making ibuprofen itself insoluble and improving the coating density of ibuprofen sustained-release capsules, while improving production efficiency.

[0008] Polyvinyl pyrrolidone has good dispersibility and film-forming property, can improve the dispersibility of ibuprofen in ethanol, and forms a film after secondary coating of the isolation layer micro-pills in a centrifugal coating machine, wraps the ibuprofen drug, improves the adhesion of the drug layer on the isolation layer, and makes the ibuprofen micro-pills slowly released after disintegration, thereby achieving a sustained release effect; polyvinyl pyrrolidone also plays the role of drug adhesive and pore-forming agent when mixed with ibuprofen in the present invention, tightly adheres the ibuprofen drug to the surface of the isolation layer, improves the adhesion of the coating, and prevents the ibuprofen micro-pills from breaking or separating during subsequent processing; at the same time, the coating layer is adjusted to a certain extent, and can play the role of adjusting the pore size and controlling the pore size distribution during the coating process, forming a more uniform and fine pore structure, enhancing the permeability of ibuprofen and polyvinyl pyrrolidone in the internal structure of the drug coating layer, thereby controlling the release rate of the drug and improving the solubility and bioavailability of ibuprofen.

[0009] To achieve the above object, the present invention provides a method for preparing ibuprofen sustained-release capsules, comprising the following steps:

[0010] (1) adding the isolation layer auxiliary material to ethanol, stirring until dissolved, starting the centrifugal coating machine, adding the pellet core, setting the spraying speed to 500-600 rpm and the atomization pressure to 0.6-0.7 MPa, stopping the spraying after the coating is completed, and drying at 40-50° C. for 8-10 hours to obtain isolation layer micropellets; providing the isolation layer can improve the adhesion of ibuprofen on the isolation layer, so that the subsequent ibuprofen coating effect on the micropellets is better;

[0011] (2) adding polyvinyl pyrrolidone and ibuprofen to ethanol in sequence, stirring until dissolved, starting the centrifugal coating machine, adding the isolation layer micropellets, setting the spraying speed to 500-600 rpm and the atomization pressure to 0.6-0.7 MPa, stopping the spraying after the coating is completed, and drying at 40-50° C. for 8-10 hours to obtain ibuprofen micropellets;

[0012] (3) Add ibuprofen pellets into the mixer, set the speed to 10-12 rpm, and mix for 15-30 min;

[0013] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell to obtain the ibuprofen sustained-release capsule.

[0014] The weight proportions of the raw materials in the preparation method are: 0.5-1 parts of isolation layer auxiliary materials, 15-20 parts of ethanol, 8-10 parts of pellet cores, 28-30 parts of ibuprofen, 0.15-0.25 parts of polyvinyl pyrrolidone, and 60-100 parts of ethanol.

[0015] Preferably, the mass ratio of ibuprofen to polyvinyl pyrrolidone is 150:1.

[0016] The ball core in step (1) is one of a sucrose ball core, a microcrystalline cellulose ball core, and a starch ball core; preferably a sucrose ball core.

[0017] In the step (1), the auxiliary material of the isolation layer is one of stearic acid and modified stearic acid or a mixture thereof.

[0018] The filling amount of the ibuprofen sustained-release capsules in step (4) is 0.4 g / capsule, and the filling amount difference is within the range of ±6.5%.

[0019] Stearic acid is added alone as an isolation layer auxiliary material to coat the micropills. Since stearic acid is a fat-soluble substance and has certain fluidity and plasticity, when stearic acid forms a coating on the micropills, it may form a relatively loose isolation layer instead of tightly wrapping the surface of the micropills. The density of the isolation layer will also affect the coating density of the drug, which may lead to an accelerated drug release rate and a reduced residence time of the drug in the gastrointestinal tract, thereby affecting the absorption process of the drug. In order to overcome this problem, stearic acid is modified in the present invention and used as an isolation layer auxiliary material.

[0020] The preparation method of the modified stearic acid is as follows:

[0021] Take β-cyclodextrin and stearic acid and add them to ethanol, stir at 80-90° C. for 1-2 hours, add N-aminoethyl-3-aminopropylmethyldimethoxysilane and water, stir at room temperature for 10-30 minutes, add 10-20wt% sodium hydroxide-ethanol aqueous solution to adjust the pH to alkaline, stir at 50-60° C. for 10-30 minutes, and place at 100-120° C. for drying for 1-3 hours to obtain modified stearic acid.

[0022] The weight ratio of the beta-cyclodextrin, stearic acid, ethanol, N-aminoethyl-3-aminopropylmethyldimethoxysilane and water is 0.2-0.3: 0.5-0.8: 8-10: 0.05-0.1: 1-2.

[0023] The concentration of the ethanol aqueous solution in the sodium hydroxide-ethanol aqueous solution is 90-95wt%.

[0024] The pH is adjusted to alkaline pH = 9-10.

[0025] In the preparation method of the ibuprofen sustained-release capsules of the present invention, the pellet cores are first coated with an isolation layer using a centrifugal coating machine, i.e., the first coating layer, and then ibuprofen and polyvinyl pyrrolidone are dissolved in ethanol to coat the drug-containing layer, i.e., the second coating layer, and finally the ibuprofen sustained-release capsules are prepared by mixing and capsule filling.

[0026] The pellet core is mainly used as the core material of enteric-coated pellet preparations and sustained-release pellet preparations in pharmaceutical preparations. It is a pharmaceutical excipient. In ibuprofen sustained-release capsules, it can help the drug to be gradually released in the body, prolong the drug's action time, thereby reducing the number of medications and improving patients' medication compliance; it can also help reduce drug irritation to the gastrointestinal tract and reduce the incidence of adverse reactions; it can improve the dispersibility and bioavailability of ibuprofen drugs, evenly apply the drugs, and enhance the therapeutic effect of the drugs. Beneficial effects of the present invention:

[0027] Compared with the prior art, in the preparation method of the ibuprofen sustained-release capsule of the present invention, the isolation layer is first coated on the pellet core by a centrifugal coating machine, i.e., the first layer of coating, and then ibuprofen and polyvinyl pyrrolidone are dissolved in ethanol to coat the drug-containing layer, i.e., the second layer of coating, and finally the ibuprofen sustained-release capsule is prepared by mixing and capsule filling. Polyvinyl pyrrolidone plays the role of a drug adhesive and a pore-forming agent in the present invention, polyvinyl pyrrolidone and ibuprofen are added to ethanol and mixed, and the isolation layer micropills are coated twice by a centrifugal coating machine, so that ibuprofen is better adhered to the surface of the pellet core. The sustained-release performance is achieved by the difficulty in solubility of ibuprofen itself and the improvement of the coating density, and the production efficiency is improved at the same time. DETAILED DESCRIPTION

[0028] The parameters of the specific chemical substances used in the examples are from the following sources:

[0029] Ibuprofen: white crystalline powder, pharmaceutical grade;

[0030] Sucrose pellet core: particle size is 300μm, pharmaceutical grade.

[0031] Example 1

[0032] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0033] (1) adding 8 kg of stearic acid to 150 kg of ethanol, stirring until dissolved, starting a centrifugal coating machine, adding 90 kg of sucrose pellet cores, setting the spraying speed to 600 rpm and the atomization pressure to 0.7 MPa, stopping the spraying after coating, and drying at 45° C. for 10 hours to obtain isolated layer pellets; providing an isolated layer can improve the adhesion of ibuprofen on the isolated layer, so that the subsequent ibuprofen coating effect on the pellets is better;

[0034] (2) 2 kg of polyvinyl pyrrolidone and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 98 kg of isolation layer pellets were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45° C. for 10 hours to obtain ibuprofen pellets;

[0035] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0036] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0037] Comparative Example 1

[0038] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0039] (1) 8 kg of stearic acid, 2 kg of polyvinyl pyrrolidone and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 90 kg of sucrose pellet cores were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45° C. for 10 hours to obtain ibuprofen pellets;

[0040] (2) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0041] (3) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0042] Example 1 is provided with an isolation layer, while Comparative Example 1 is not provided with an isolation layer. Providing an isolation layer can improve the adhesion of ibuprofen on the isolation layer, so that the subsequent ibuprofen application effect on the micropills is better. In addition, the isolation layer can also effectively protect the sucrose pellet core, reduce the damage of the pellet core, improve the integrity of the pellet core, and further ensure the yield rate of the ibuprofen micropills.

[0043] Comparative Example 2

[0044] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0045] (1) Add 8 kg of stearic acid to 150 kg of ethanol, stir until dissolved, start the centrifugal coating machine, add 90 kg of sucrose pellets, set the spray speed to 600 rpm and the atomization pressure to 0.7 MPa, stop spraying after coating, and dry at 45 ° C for 10 hours to obtain isolation layer pellets;

[0046] (2) adding 2 kg of polyvinyl pyrrolidone to 800 kg of ethanol in sequence, stirring until dissolved to obtain an adhesive; starting a centrifugal coating machine, adding 98 kg of isolation layer pellets, adding 300 kg of ibuprofen and spraying the adhesive at the same time, setting the spray speed to 600 rpm and the atomization pressure to 0.7 MPa, stopping the spraying after the coating is completed, and drying at 45° C. for 10 hours to obtain ibuprofen pellets;

[0047] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0048] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0049] Example 1 is an ibuprofen solution drug, and Control Example 2 is an ibuprofen powder drug. Powder drug application has poor uniformity, and the stability of the obtained ibuprofen micropill dissolution curve is poor. The root cause is that the particle size uniformity of the ibuprofen raw material powder is not good. If a stable dissolution curve is to be obtained, high-quality ibuprofen raw material powder is required. Example 1 of the present invention adopts liquid drug application, and the dissolution curve is stable, and at the same time, it has more excellent sustained-release performance.

[0050] Example 2

[0051] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0052] (1) Add 8 kg of stearic acid to 150 kg of ethanol, stir until dissolved, start the centrifugal coating machine, add 90 kg of sucrose pellets, set the spray speed to 600 rpm and the atomization pressure to 0.7 MPa, stop spraying after coating, and dry at 45 ° C for 10 hours to obtain isolation layer pellets;

[0053] (2) 2 kg of poloxamer and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 98 kg of isolation layer pellets were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45° C. for 10 hours to obtain ibuprofen pellets;

[0054] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0055] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0056] Example 3

[0057] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0058] (1) Add 8 kg of stearic acid to 150 kg of ethanol, stir until dissolved, start the centrifugal coating machine, add 90 kg of sucrose pellets, set the spray speed to 600 rpm and the atomization pressure to 0.7 MPa, stop spraying after coating, and dry at 45 ° C for 10 hours to obtain isolation layer pellets;

[0059] (2) 2 kg of polyvinyl acetate and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 98 kg of isolation layer pellets were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45 ° C for 10 hours to obtain ibuprofen pellets;

[0060] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0061] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0062] Example 4

[0063] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0064] (1) Add 8 kg of modified stearic acid to 150 kg of ethanol, stir until dissolved, start the centrifugal coating machine, add 90 kg of sucrose pellets, set the spray speed to 600 rpm and the atomization pressure to 0.7 MPa, stop spraying after coating, and dry at 45 ° C for 10 hours to obtain isolation layer pellets;

[0065] (2) 2 kg of polyvinyl pyrrolidone and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 98 kg of isolation layer pellets were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45° C. for 10 hours to obtain ibuprofen pellets;

[0066] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0067] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0068] The modification method of the modified stearic acid in step (1) is as follows:

[0069] Take 0.2kg of β-cyclodextrin and 0.6kg of stearic acid and add them to 8.5kg of ethanol, stir at 80℃ for 1 hour, add 0.05kg of N-aminoethyl-3-aminopropylmethyldimethoxysilane and 1.5kg of water, stir at room temperature for 20 minutes, add 15wt% sodium hydroxide-90wt% ethanol aqueous solution to adjust the pH to 9.5, stir at 50℃ for 15 minutes, and place at 100℃ for drying for 1 hour to obtain modified stearic acid.

[0070] Modified stearic acid is used as the first coating isolation layer to separate the pill core from the drug-containing layer and isolate the drug so that the drug does not come into direct contact with the pill core. At the same time, it protects the pill core and prevents it from being damaged during subsequent processing. β-cyclodextrin contains abundant hydroxyl structures, one of which is esterified with the carboxyl group in the long chain of stearic acid to form cross-linked grafting, so that the original stearic acid fatty acid chain has hydroxyl groups, and then N-aminoethyl-3-aminopropylmethyldimethoxysilane is added, which is hydrolyzed in an ethanol aqueous solution to generate silanol groups and form hydrogen bonds with the hydroxyl groups on the β-cyclodextrin / stearic acid long chain, so that N-aminoethyl-3-aminopropylmethyldimethoxysilane is physically adsorbed on the surface of the β-cyclodextrin / stearic acid long chain to obtain modified stearic acid, and the pellet core is coated with a centrifugal coating machine to obtain isolation layer micropills. During the drying process, the hydrogen bonds are dehydrated and condensed, and the N-aminoethyl-3-aminopropylmethyldimethoxysilane molecules are converted from physical adsorption to more stable chemical adsorption. At the same time, dehydration condensation also occurs between the silanol groups to form a cross-linked structure, so that a dense isolation layer is formed on the surface of the isolation layer micropills, which has better density than adding stearic acid isolation layer auxiliary materials alone, and improves the adhesion of the isolation layer to polyvinyl pyrrolidone and ibuprofen.

[0071] Example 5

[0072] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0073] (1) adding 8 kg of modified stearic acid to 150 kg of ethanol, stirring until dissolved, starting a centrifugal coating machine, adding 90 kg of sucrose pellet cores, setting the spraying speed to 600 rpm and the atomization pressure to 0.7 MPa, stopping the spraying after coating, drying at 45° C. for 10 hours, and obtaining isolation layer pellets, thereby improving the adhesion of ibuprofen on the isolation layer and making the subsequent ibuprofen application to the pellets more effective;

[0074] (2) 2 kg of polyvinyl pyrrolidone and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 98 kg of isolation layer pellets were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45° C. for 10 hours to obtain ibuprofen pellets;

[0075] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0076] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0077] The modification method of the modified stearic acid in step (1) is as follows:

[0078] Take 0.2kg of β-cyclodextrin and 0.6kg of stearic acid and add them to 8.5kg of ethanol, stir at 80°C for 1 hour, add 0.05kg of 3-aminopropyltrimethoxysilane and 1.5kg of water, stir at room temperature for 20 minutes, add 15wt% sodium hydroxide-90wt% ethanol aqueous solution to adjust the pH to 9.5, stir at 50°C for 15 minutes, and place at 100°C for drying for 1 hour to obtain modified stearic acid.

[0079] Example 6

[0080] A method for preparing ibuprofen sustained-release capsules comprises the following steps:

[0081] (1) Add 8 kg of modified stearic acid to 150 kg of ethanol, stir until dissolved, start the centrifugal coating machine, add 90 kg of sucrose pellets, set the spray speed to 600 rpm and the atomization pressure to 0.7 MPa, stop spraying after coating, and dry at 45 ° C for 10 hours to obtain isolation layer pellets;

[0082] (2) 2 kg of polyvinyl pyrrolidone and 300 kg of ibuprofen were added to 800 kg of ethanol in sequence, stirred until dissolved, the centrifugal coating machine was turned on, 98 kg of isolation layer pellets were added, the spraying speed was set to 600 rpm and the atomization pressure was set to 0.7 MPa. After the coating was completed, the spraying was stopped, and the pellets were dried at 45° C. for 10 hours to obtain ibuprofen pellets;

[0083] (3) Add ibuprofen pellets into the mixer, set the speed to 10 rpm, and mix for 20 min;

[0084] (4) Calculate the filling amount according to the content of ibuprofen, and fill it into the capsule shell. The filling amount of the ibuprofen sustained-release capsule is 0.4 g / capsule, thus obtaining the ibuprofen sustained-release capsule.

[0085] The modification method of the modified stearic acid in step (1) is as follows:

[0086] Take 0.2kg of β-cyclodextrin and 0.6kg of stearic acid and add them to 8.5kg of ethanol, stir at 80°C for 1 hour, add 0.05kg of 3-aminopropyltriethoxysilane and 1.5kg of water, stir at room temperature for 20 minutes, add 15wt% sodium hydroxide-90wt% ethanol aqueous solution to adjust the pH to 9.5, stir at 50°C for 15 minutes, and place at 100°C for drying for 1 hour to obtain modified stearic acid.

[0087] Test Example 1

[0088] Dissolution Testing

[0089] The ibuprofen pellets obtained in step (2) of the preparation method of Comparative Examples 1-2 and Examples 1-6 were used as samples. The test procedure was in accordance with the third method, small cup method, in the dissolution and release determination method of Part IV of the Pharmacopoeia of the People's Republic of China. Six parallel tests and one control group were set up for each group. The control group was ibuprofen. The test data were averaged and summarized as shown in Table 1.

[0090] Take phosphate buffer (take 68.05g potassium dihydrogen phosphate, add 56mml 1mol / L sodium hydroxide solution, dilute with water to 10000ml, shake well, pH value should be 6.0±0.05) 900ml as dissolution medium, rotate at 30 revolutions per minute, operate according to the law; after 1 hour, 2 hours, 4 hours and 7 hours, take 5ml of dissolution solution respectively, and immediately add dissolution medium of the same temperature and volume, filter with microporous filter membrane, take the filtrate, detect according to HPLC method, and calculate the dissolution amount; take 15mg of ibuprofen reference substance, accurately weigh, put in 50ml volumetric bottle, add 2mL of methanol to dissolve, dilute to scale with dissolution medium, shake well, and measure in the same way. Calculate the dissolution amount of each particle at 1 hour, 2 hours, 4 hours and 7 hours, which should be 10%-35%, 25%-55%, 50%-80% and more than 75% of the labeled amount respectively, and all should meet the requirements.

[0091] Table 1 Dissolution test

[0092] 1h(%) 2h(%) 4h(%) 7h(%) Example 1 23.6 38.6 58.7 85.0 Comparative Example 1 26.1 40.7 71.0 96.2 Comparative Example 2 22.0 36.7 63.5 87.8 Example 2 22.2 36.9 63.8 86.2 Example 3 21.7 36.0 61.4 85.6 Example 4 23.4 36.5 56.2 81.3 Example 5 23.3 38.3 62.8 84.2 Example 6 23.2 38.2 61.7 83.7

[0093] By comparing the dissolution test data of Test Example 1, it can be seen that the isolation layer auxiliary material of the double-layer coated ibuprofen sustained-release capsules prepared in Example 1 is stearic acid, wherein Example 1 adds polyvinyl pyrrolidone and ibuprofen before coating; Comparative Example 1 has no isolation layer, and the ibuprofen drug layer is directly coated on the surface of the sucrose pill core. The ibuprofen sustained-release capsules obtained in Comparative Example 1 have a significant increase in drug dissolution at 4h, a high drug dissolution rate at 7h, and poor sustained-release performance; the ibuprofen in Comparative Example 2 are all powder-coated, and polyvinyl pyrrolidone in ethanol is used as a binder. Due to the poor uniformity of the powder-coated drug, the dissolution curve of the obtained ibuprofen pellets is Poor stability, poor sustained-release effect; the poloxamer added in Example 2 is mixed with ibuprofen, and the polyvinyl acetate added in Example 3 is mixed with ibuprofen. By comparison, it is found that polyvinyl pyrrolidone has a better sustained-release effect on ibuprofen; the isolation layer excipient in Examples 4-6 is modified stearic acid. By comparing Example 4 with Example 1, it can be seen that the isolation layer excipient will affect the dissolution of the ibuprofen drug to a certain extent. The sustained-release effect of Examples 5-6 is less than that of Example 4. The possible reason is that the isolation layer has a subtle change in the adsorption of the drug layer. The isolation layer has high density and high bioavailability, which ensures better sustained-release of the drug, continuous dissolution and prolonged efficacy.

[0094] Test Example 2

[0095] Disintegration time test

[0096] The ibuprofen pellets obtained in step (2) of the preparation methods of Comparative Examples 1-2 and Examples 1-6 were used as samples. The test procedure was in accordance with General Rule 0921-Disintegration Time Test Method in Part IV of the Pharmacopoeia of the People's Republic of China, and 6 pellets were taken for each group of samples.

[0097] From the drug disintegration time test of Test Example 2, it can be seen that the disintegration speed of the ibuprofen pellets obtained in step (2) of the preparation methods of Comparative Examples 1-2 and Examples 1-6 is less than 15 min, which meets the standard.

Claims

1. A method for preparing ibuprofen sustained-release capsules, characterized in that: The following steps are involved: (1) Add the isolation layer excipients to ethanol, stir until dissolved, start the centrifugal coating machine, add the pellet cores, set the spray speed to 500-600 rpm and the atomization pressure to 0.6-0.7 MPa, stop spraying after coating, dry at 40-50°C for 8-10 hours to obtain isolation layer pellets; Setting the isolation layer can improve the adhesion of ibuprofen on the isolation layer, so that the subsequent ibuprofen application to the micro-pellets has a better effect; (2) Add polyvinyl pyrrolidone and ibuprofen to ethanol in sequence, stir until dissolved, start the centrifugal coating machine, add the isolation layer micropellets, set the spray speed to 500-600 rpm and the atomization pressure to 0.6-0.7 MPa, stop spraying after coating, dry at 40-50°C for 8-10 hours, and obtain ibuprofen micropellets; (3) Add ibuprofen pellets into the mixer, set the speed to 10-12 rpm, and mix for 15-30 min; (4) converting the filling amount according to the content of ibuprofen, and filling the ibuprofen into the capsule shell to obtain the ibuprofen sustained-release capsule; The pellet core in step (1) is a sucrose pellet core; In step (1), the auxiliary material of the isolation layer is modified stearic acid; The preparation method of the modified stearic acid is as follows: beta-cyclodextrin and stearic acid are added to ethanol, stirred at 80-90° C. for 1-2 hours, N-aminoethyl-3-aminopropylmethyldimethoxysilane and water are added, stirred at room temperature for 10-30 minutes, 10-20wt% sodium hydroxide-ethanol aqueous solution is added to adjust the pH to alkaline, stirred at 50-60° C. for 10-30 minutes, and dried at 100-120° C. for 1-3 hours to obtain the modified stearic acid.

2. The method for preparing the ibuprofen sustained-release capsule according to claim 1, wherein: The weight parts of each raw material are: 0.5-1 parts of isolation layer auxiliary materials, 15-20 parts of ethanol, 8-10 parts of pellet core; 28-30 parts of ibuprofen, 0.15-0.25 parts of polyvinyl pyrrolidone, 60-100 parts of ethanol.

3. The method for preparing the ibuprofen sustained-release capsules as claimed in claim 1 or 2, characterized in that: The mass ratio of ibuprofen to polyvinyl pyrrolidone is 150:

1.

4. The method for preparing the ibuprofen sustained-release capsule according to claim 1, wherein: The filling amount of the ibuprofen sustained-release capsules in step (4) is 0.4 g / capsule, and the filling amount difference is within the range of ±6.5%.

5. An ibuprofen sustained-release capsule, characterized in that: The invention is prepared by the preparation method according to any one of claims 1 to 4.

Citation Information

Cited By

  • Preparation method and application of ibuprofen sustained-release pellets

    CN122701690A